MLYS
MLYS clinical trials: Mineralys Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Mineralys Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 6
- Trials linked
- 6
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MLYS on the catalyst calendar · MLYS registry changes
- Primary completion Dec 30, 2025ActualPhase 3NCT05968430Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionMineralys Therapeutics Inc. · HypertensionActive, not recruitingMLYSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 17, 2025ActualPhase 2NCT06785454A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and HypertensionMineralys Therapeutics Inc. · Obstructive Sleep ApneaCompletedMLYSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 27, 2025ActualPhase 2NCT06150924Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and...Mineralys Therapeutics Inc. · Chronic Kidney DiseaseCompletedMLYSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 10, 2024ActualPhase 3NCT06153693Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant HypertensionMineralys Therapeutics Inc. · HypertensionCompletedMLYSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 15, 2025ActualPhase 2NCT05769608A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive...Mineralys Therapeutics Inc. · HypertensionCompletedMLYSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 7, 2022ActualPhase 2NCT05001945Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled HypertensionMineralys Therapeutics Inc. · Hypertension, RenalCompletedMLYSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner